Ptc Therapeutics

Developer of small molecule drugs for the treatment of rare diseases

placeSouth Plainfield, New Jersey, United States calendar_todayFounded 1998 groups995 employees language ptcbio.com

Registered entities

Innovation

208 patent families (111 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 44,292 times.

YearFilings
201535
201646
201732
201827
201929
202057
202163
202256
202357
202446
202544
202610

Social engagement

Social engagement: 88.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

30 investors on record; lead investors include Bay City Capital, UBS, HBM Healthcare Investments, Vulcan Capital; 2 have since exited.

Investor typeCountShare
Venture capital1137%
Private equity620%
Bank & private debt27%
Other / undisclosed1137%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

26 Mar 2026 · Contract, Clinical Trial Associate · Mountain View

25 Jun 2025 · Head of IT Security · Warren

5 Jun 2025 · Contract, Lab Technician, Biology · Mountain View

1 May 2025 · Research Fellow, Formulation Development Scientist (Small Molecule) · null

1 May 2025 · Director - Planning, Strategy & Project Management · null

Based on job postings tracked across public sources.

Recent activity

5 May 2026
Event
Investor Conferences
Coming soon